54 related articles for article (PubMed ID: 3141591)
1. Phase I study of recombinant gamma-interferon (rIFN-gamma).
Boman BM; Gagen MM; Bonnem E; Ajani JA; Schmidt S; Dimery IW; Golando J; Neidhart J
J Biol Response Mod; 1988 Oct; 7(5):438-46. PubMed ID: 3141591
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.
Von Hoff DD; Fleming TR; Macdonald JS; Goodman PJ; Van Damme J; Brown TD; O'Rourke T; Feun LG; Keppen MD
J Biol Response Mod; 1990 Dec; 9(6):584-7. PubMed ID: 2127424
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes.
Halme M; Maasilta P; Repo H; Leirisalo-Repo M; Taskinen E; Mattson K; Cantell K
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):283-91. PubMed ID: 8061901
[TBL] [Abstract][Full Text] [Related]
5. Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer.
van der Burg M; Edelstein M; Gerlis L; Liang CM; Hirschi M; Dawson A
J Biol Response Mod; 1985 Jun; 4(3):264-72. PubMed ID: 3926954
[TBL] [Abstract][Full Text] [Related]
6. The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon.
Small EJ; Weiss GR; Malik UK; Walther PJ; Johnson D; Wilding G; Kuzel T; Bajamonde A; Paton V
Cancer J Sci Am; 1998; 4(3):162-7. PubMed ID: 9612597
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon gamma in the treatment of metastatic renal cell carcinoma. Results of a phase II trial.
Otto U; Conrad S; Schneider AW; Klosterhalfen H
Arzneimittelforschung; 1988 Nov; 38(11):1658-60. PubMed ID: 3145743
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.
Vey N; Viens P; Fossat C; Olive D; Sainty D; Baume D; Stoppa AM; Bouabdallah R; Brandely M; Gastaut JA; Maraninchi D; Blaise D
Eur Cytokine Netw; 1997 Dec; 8(4):389-94. PubMed ID: 9459619
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
11. A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
Sherwin SA; Foon KA; Abrams PG; Heyman MR; Ochs JJ; Watson T; Maluish A; Oldham RK
J Biol Response Mod; 1984 Dec; 3(6):599-607. PubMed ID: 6439828
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.
Pappas PG; Bustamante B; Ticona E; Hamill RJ; Johnson PC; Reboli A; Aberg J; Hasbun R; Hsu HH
J Infect Dis; 2004 Jun; 189(12):2185-91. PubMed ID: 15181565
[TBL] [Abstract][Full Text] [Related]
13. Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study.
Kowalzick L; Rogozinski T; Wimheuer R; Pilz J; Manske U; Scholz A; Fierlbeck G; Mohr P; Ochsendorf F; Wagner G; Gaus W; Brzoska J; Jablonska S
Eur J Dermatol; 2002; 12(6):558-61. PubMed ID: 12459527
[TBL] [Abstract][Full Text] [Related]
14. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
Atkins MB; Robertson MJ; Gordon M; Lotze MT; DeCoste M; DuBois JS; Ritz J; Sandler AB; Edington HD; Garzone PD; Mier JW; Canning CM; Battiato L; Tahara H; Sherman ML
Clin Cancer Res; 1997 Mar; 3(3):409-17. PubMed ID: 9815699
[TBL] [Abstract][Full Text] [Related]
15. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation.
Safdar A; Rodriguez G; Ohmagari N; Kontoyiannis DP; Rolston KV; Raad II; Champlin RE
Cancer; 2005 Feb; 103(4):731-9. PubMed ID: 15641032
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.
Green MD; Speyer JL; Hochster HS; Liebes LF; Dunleavy S; Widman T; Wernz JC; Blum RH; Spiegel RJ; Muggia FM
Cancer Res; 1988 May; 48(9):2574-8. PubMed ID: 3356017
[TBL] [Abstract][Full Text] [Related]
17. [Biological properties and clinical applications of interferon gamma (IFN-gamma)].
Robak T
Acta Haematol Pol; 1994; 25(1):19-29. PubMed ID: 8209610
[TBL] [Abstract][Full Text] [Related]
18. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
Greenblatt MS; Mangalik A; Ferguson J; Elias L
Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
[TBL] [Abstract][Full Text] [Related]
19. Low dose interferon gamma for refractory Crohn's disease.
Debinski H; Forbes A; Kamm MA
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):403-6. PubMed ID: 9494846
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells.
Fushimi M; Tokura Y; Sachi Y; Hashizume H; Sudo H; Wakita H; Furukawa F; Takigawa M
Br J Dermatol; 1996 Apr; 134(4):766-72. PubMed ID: 8733389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
